WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for UTHR

Based on 7 analysts offering 12 month price targets for United Therapeutics Corp.
Min Forecast
$215.00-8.88%
Avg Forecast
$298.00+26.3%
Max Forecast
$330.00+39.86%

Should I buy or sell UTHR stock?

Based on 7 analysts offering ratings for United Therapeutics Corp.
Strong Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their UTHR stock forecasts and price targets.

UTHR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-07
lockedlocked$00.00+00.00%2024-02-22
lockedlocked$00.00+00.00%2024-02-22
lockedlocked$00.00+00.00%2024-02-12
lockedlocked$00.00+00.00%2024-02-05
JP Morgan
Bottom 34%
34
Strong BuyMaintains$294.00+24.60%2023-11-02
Morgan Stanley
Top 7%
94
Strong BuyMaintains$314.00+33.08%2023-11-02

1 of 1

Forecast return on equity

Is UTHR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is UTHR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

UTHR revenue forecast

What is UTHR's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$2.6B+12.7%
Avg 2 year Forecast
$2.8B+20.75%
Avg 3 year Forecast
$3.1B+31.75%
UTHR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

UTHR earnings growth forecast

How is UTHR forecast to perform vs Biotechnology companies and vs the US market?
Company
8.78%
Industry
7.17%
Market
21.46%
UTHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
UTHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
UTHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

UTHR revenue growth forecast

How is UTHR forecast to perform vs Biotechnology companies and vs the US market?
Company
9.49%
Industry
37.04%
Market
9.92%
UTHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
UTHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

UTHR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
UTHR$235.95$298.00+26.30%Strong Buy
INCY$51.18$74.69+45.94%Buy
SRPT$127.39$155.54+22.10%Strong Buy
TECH$62.66$78.43+25.17%Strong Buy
ROIV$10.88$17.11+57.27%Strong Buy
View Top Biotech Stocks

United Therapeutics Stock Forecast FAQ

Is United Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: UTHR) stock is to Strong Buy UTHR stock.

Out of 7 analysts, 3 (42.86%) are recommending UTHR as a Strong Buy, 3 (42.86%) are recommending UTHR as a Buy, 1 (14.29%) are recommending UTHR as a Hold, 0 (0%) are recommending UTHR as a Sell, and 0 (0%) are recommending UTHR as a Strong Sell.

If you're new to stock investing, here's how to buy United Therapeutics stock.

What is UTHR's revenue growth forecast for 2024-2026?

(NASDAQ: UTHR) United Therapeutics's forecast annual revenue growth rate of 9.49% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

United Therapeutics's revenue in 2024 is $2,327,500,000.On average, 7 Wall Street analysts forecast UTHR's revenue for 2024 to be $123,438,987,038, with the lowest UTHR revenue forecast at $118,029,419,056, and the highest UTHR revenue forecast at $130,976,165,957. On average, 7 Wall Street analysts forecast UTHR's revenue for 2025 to be $132,259,358,362, with the lowest UTHR revenue forecast at $120,806,908,499, and the highest UTHR revenue forecast at $147,016,541,605.

In 2026, UTHR is forecast to generate $144,309,498,804 in revenue, with the lowest revenue forecast at $126,070,312,640 and the highest revenue forecast at $170,936,870,614.

What is UTHR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: UTHR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is UTHR's Price Target?

According to 7 Wall Street analysts that have issued a 1 year UTHR price target, the average UTHR price target is $298.00, with the highest UTHR stock price forecast at $330.00 and the lowest UTHR stock price forecast at $215.00.

On average, Wall Street analysts predict that United Therapeutics's share price could reach $298.00 by Mar 7, 2025. The average United Therapeutics stock price prediction forecasts a potential upside of 26.3% from the current UTHR share price of $235.95.

What is UTHR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: UTHR) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.